RxDoctor Payments Data

Jennifer Lane

Family · Rogersville, TNNPI 1326270570

Payments from drug & device makers

$1,839in general payments, 2019–2025

Across 115 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$663
  • Lilly USA, LLC$299
  • AbbVie$297
  • Bayer$84
  • Exact Sciences$81
  • GSK$79
  • plus $337 from 9 others

What the payments were for

  • Food & beverage$1,839100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,839 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,781
Medicare patients
131
Services billed
1,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$110,741
TrulicityDulaglutide23$39,097
FarxigaDapagliflozin Propanediol33$25,452
MounjaroTirzepatide23$24,490
JardianceEmpagliflozin16$24,346
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$20,257
XareltoRivaroxaban18$17,993
OzempicSemaglutide18$17,042
JanuviaSitagliptin Phosphate13$13,043
Tresiba Flextouch U-100Insulin Degludec26$10,976
Breo ElliptaFluticasone/Vilanterol22$9,904
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,336
Omeprazole226$4,952
Rosuvastatin Calcium342$2,971
Atorvastatin Calcium226$2,840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$299$63,58846 claims
AstraZenecaFarxiga, Breztri Aerosphere$51$32,78745 claims
GSKTrelegy Ellipta, Breo Ellipta$79$30,16151 claims
Novo NordiskOzempic$663$17,04218 claims
AbbVieSynthroid$297$1,69121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Rogersville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →